For example, amplification of cyclin D1 and MDM2 or mutations in TBX3 and RUNX1 are preferentially observed in luminal-like breast cancers, while mutations in p53, pRb, BRCA1 and PTEN are commonly found among basal-like tumors [1]. This evidence concerns the gene TP53 and breast carcinoma.